Recruiting

Patient Care Outreach, Navigation, Technology and Support 2.0

This is a feasibility study employing virtual patient navigation for underserved individuals who speak English, Chinese or Spanish and were diagnosed with breast cancer or cardiovascular disease to determine the extent of usability for a virtual patient navigation portal serving people in underserved communities. While not able to entirely replace in-person interactions, virtual patient navigation may be used to expand reach and availability of navigation services to a much greater segment of the population.

ClinicalTrials.gov IDNCT06648278

PhaseNA

Enrollment260

SponsorUniversity of California, San Francisco

Age18 Years and older

SexALL

I'm interested View official listing

Conditions studied

Breast Cancer, Cardiovascular Diseases

About this study

Interventions

Behavioral: Patient Navigation Program — Online health tool
Other: Quality-of-Life (QOL) Assessment — Online surveys to assess QOL
Other: Survey Administration — Ancillary studies

Primary outcomes

Proportion of participants who reported satisfaction with COUNTS program (Up to 6 months)
Rate of Participation (Up to 6 months)
Utilization rate (Up to 6 months)

Eligibility information

Inclusion Criteria: For Focus groups: * Breast cancer patients: Diagnosed with breast cancer, ages 18 or older, speaks English, Mandarin/Cantonese, or Spanish * Navigators: any patient navigator who has provided care to underserved populations diagnosed with cancer For Portal Implementation phase: * Ages 18 or older * Speaks English, Mandarin/Cantonese, Spanish, * Has any stage breast cancer * Has access to a phone that is able to receive text messages, is willing to stay in the study for six-seven months. Family User experience survey: * Family member or friend who may have assisted breast cancer participant with registration, accessing or otherwise assisting breast cancer family member or friend participant with the online portal. Exclusion Criteria: * Any medical or psychological conditions precluding informed consent

Study locations

Zuckerberg San Francisco General Hospital, San Francisco, California 94110 United States
University of California, San Francisco, San Francisco, California 94143 United States

Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.

Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-10-20.